Navigating the Shift from Animal Testing to NAMs in Drug Development

Short on time? Watch focused clips featuring practical insights, implementation strategies, and expert perspectives from across the session before diving into the full webinar.

Whether you’re evaluating NAMs for a development program or preparing for evolving FDA expectations, our experts can help. Use the Ask Our Experts link below to discuss your development strategy, regulatory readiness, and approach to integrating NAMs and MIDD.